Patents by Inventor David S. Latchman

David S. Latchman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutant herpes simplex viruses and uses thereof
    Patent number: 6719982
    Abstract: The present invention provides a herpes simplex virus strain having a functional ICP27 gene and lacking at lease a functional ICP4 gene and a functional ICP34.5 gene. It also provides the use of a herpes simplex virus strain which lacks at least a functional ICP4 gene and a functional ICP34.5 gene in the treatment of disorders of, or injuries to, the nervous system of a mammal.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: April 13, 2004
    Assignee: Biovex Limited
    Inventors: Robert S. Coffin, David S. Latchman, Nicholas J. Finnie
  • Eukaryotic gene expression cassette and uses thereof
    Publication number: 20030219409
    Abstract: An expression cassette comprising a herpes simplex virus latency-associated transcript P2 region, a promoter and a heterologous gene operably linked in that order. The expression cassette is incorporated into herpes simplex virus vectors to allow for delivery of heterologous genes to mammalian cells for long-term expression.
    Type: Application
    Filed: January 31, 2003
    Publication date: November 27, 2003
    Applicant: BIOVEX LIMITED
    Inventors: Robert S. Coffin, David S. Latchman